Headlines

A 2025 Depo-Provera study links long-term use to higher meningioma risk. Learn what researchers found and what it may mean for future lawsuits.

A New Mexico jury found Meta Platforms Inc. liable for endangering children by misleading consumers about the safety of its social media platforms: Facebook, Instagram and WhatsApp.

Motley Rice LLC is proud to announce the addition of six new lawyers to the firm. They bring new talent to the firm’s securities fraud, product liability, toxic exposure, whistleblower, harmful drugs and defective medical device litigation teams.

Rhode Island's Office of the Attorney General released a report on child sexual abuse in the Diocese of Providence, detailing a 7-year-long investigation.

A late‑night runway collision at New York’s LaGuardia Airport left two pilots dead, dozens injured and the airport closed for hours as federal investigators launched an urgent probe into the circumstances surrounding the plane crash.

Investigation reveals resort owners and management overlooked a string of guest illnesses and at least one hospitalization prior to the 14-year-old’s carbon monoxide death

Motley Rice co-founder Joe Rice, along with proposed other class counsel and Monsanto (owned by Bayer AG) have announced a $7.25 billion tiered national class settlement agreement that could resolve tens of thousands of pending civil claims filed by individuals diagnosed with non-Hodgkin’s Lymphoma (NHL) after…

Motley Rice LLC, as co-lead counsel, announces a $110 million preliminary settlement agreement to resolve a shareholder derivative action brought on behalf of Wells Fargo investors.

Cameran Gilliam and Avery Upchurch have joined Motley Rice in Mt. Pleasant, S.C.

The United States Judicial Panel on Multidistrict Litigation has created a separate MDL for lawsuits alleging vision loss linked to GLP-1 drugs.